HC Wainwright & Co. Maintains Buy on Niagen Bioscience, Lowers Price Target to $11
Niagen Bioscience Inc NAGE
$3.65
▼ -3.95%
($-0.15)
Open
$3.74
Prev Close
$3.80
Day Range
$3.60 – $3.79
52W Range
$3.71 – $14.69
Market Cap
$290.70M
P/E (TTM)
15.56
Beta
2.10
EPS (TTM)
$0.22
📋 Company Profile
| Industry | Consumer products |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2007-06-25 |
| Shares Out. | 80,080,000 |
| Website | niagenbioscience.com/ ↗ |
| Phone | 13103886706 |
Niagen Bioscience Inc is a publicly traded company under the ticker symbol NAGE on the NASDAQ NMS - GLOBAL MARKET, operating in the Consumer products industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
11 analysts (2026-05-01)
📰 Latest News for NAGE
Niagen Bioscience Announces Participation in Upcoming Investor Conferences
Snap, Whirlpool, Nerdwallet And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Niagen Bioscience Keeps Full-Year Sales Forecast Intact As Q1 Revenue, Profit Climbs (UPDATED)
Niagen Bioscience (NASDAQ:NAGE) Shares Slide After Q1 Earnings Miss and Spending Guidance
Niagen Bioscience : May 2026 Investor Presentation
Niagen Bioscience, Inc. (NAGE) Q1 2026 Earnings Call Transcript
Earnings Scheduled For May 6, 2026